
PSTV
Plus Therapeutics
$3.73
−$0.10 (−2.61%)Jul 27, 2026
Key metrics
The numbers that frame PSTV today
- Market cap
- $25.67M
- P/E (TTM)
- -2.2
- EV / FCF
- -1.1
- Gross margin
- 100%
- EV / Sales
- 4.5
- ROIC
- 1,062.9%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $2.90
- 52wk High
- $23.50
Growth
Revenue and earnings trend for PSTV
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PSTV
Is Plus Therapeutics a good buy?
No. Plus Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Plus Therapeutics is selling at a very high price.
What is the market capitalization of PSTV?
Plus Therapeutics's market capitalization is $25.67M.
What is the P/E ratio for PSTV stock?
Plus Therapeutics's current P/E ratio is -2.2.
What is the 52-week high for PSTV stock?
The 52-week high for Plus Therapeutics is $23.50. The current close of $3.73 is 84.1% below that high.
What is the 52-week low for PSTV stock?
The 52-week low for Plus Therapeutics is $2.90. The current close of $3.73 is 28.6% above that low.
Does PSTV stock pay dividends?
Plus Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PSTV?
Plus Therapeutics's Debt / Equity ratio is 0.06.